Form 4 for NRIX Nurix Therapeutics, Inc.
Accepted 2026-06-25 18:49:10 ET · period of report 2026-06-25 · accession 0001817160-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-25 18:49 | 2026-06-25 | NRIX | Hansen Gwenn | CSO | S - Sale | $20.00 | -5,394 | 115.0K | -4% | -$107.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-25 | S | D | 5,394 | $20.00 | 115,005 | D | — | — | (F1) This transaction was effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person. |